Kansai Nerolac reported a good set of numbers for 1QFY17 with a 7.4% growth in revenue at Rs.10.4 bn vs Rs.9.7 bn YoY. The company reported 236 bps expansion in EBITDA margin to 17.8 with EBITDA growth at 24% YoY. Recurring PAT increased by 33% to Rs.1265 mn from Rs.952 mn YoY. The company's strong performance driven by...